In patients with suspected MI with no obstructed coronary arteries, a stratified treatment protocol was superior to standard ...
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback